Cardlytics (CDLX)
(Delayed Data from NSDQ)
$8.38 USD
-0.77 (-8.42%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $8.71 +0.33 (3.94%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Balance Sheet
Fiscal Year End for Cardlytics, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 92 | 122 | 234 | 293 | 105 |
Receivables | 126 | 120 | 117 | 87 | 85 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 6 | 8 | 8 | 6 | 6 |
Total Current Assets | 224 | 250 | 359 | 386 | 196 |
Net Property & Equipment | 28 | 26 | 24 | 20 | 18 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 4 | 8 |
Intangibles | 312 | 406 | 868 | 0 | 0 |
Deposits & Other Assets | 3 | 3 | 2 | 2 | 2 |
Total Assets | 574 | 691 | 1,264 | 423 | 224 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 4 | 4 | 5 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 125 | 136 | 134 | 75 | 77 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 39 | 104 | 182 | 0 | 0 |
Total Current Liabilities | 171 | 249 | 327 | 81 | 78 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 3 |
Convertible Debt | 228 | 226 | 184 | 174 | 0 |
Long-Term Debt | 30 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 0 | 54 | 1 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 439 | 480 | 573 | 265 | 81 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,244 | 1,183 | 1,213 | 551 | 481 |
Retained Earnings | -1,111 | -977 | -523 | -394 | -339 |
Other Equity | 2 | 6 | 0 | 0 | 1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 135 | 212 | 691 | 157 | 143 |
Total Liabilities & Shareholder's Equity | 574 | 691 | 1,264 | 423 | 224 |
Total Common Equity | 135 | 212 | 691 | 157 | 143 |
Shares Outstanding | 39.20 | 33.10 | 33.20 | 27.40 | 22.80 |
Book Value Per Share | 3.44 | 6.39 | 20.80 | 5.74 | 6.28 |
Fiscal Year End for Cardlytics, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 98 | 92 | 90 | 92 |
Receivables | NA | 111 | 126 | 108 | 102 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 9 | 6 | 7 | 8 |
Total Current Assets | NA | 218 | 224 | 206 | 202 |
Net Property & Equipment | NA | 30 | 28 | 27 | 25 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 309 | 312 | 396 | 399 |
Deposits & Other Assets | NA | 3 | 3 | 2 | 2 |
Total Assets | NA | 569 | 574 | 635 | 633 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 4 | 4 | 3 | 2 |
Current Portion Long-Term Debt | NA | 0 | 0 | 30 | 30 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 94 | 125 | 116 | 114 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 3 | 39 | 27 | 19 |
Total Current Liabilities | NA | 103 | 171 | 179 | 168 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 228 | 227 | 227 |
Long-Term Debt | NA | 30 | 30 | 0 | 0 |
Non-Current Capital Leases | NA | 228 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 4 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 370 | 439 | 410 | 397 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 1,332 | 1,244 | 1,230 | 1,220 |
Retained Earnings | NA | -1,136 | -1,111 | -1,010 | -986 |
Other Equity | NA | 3 | 2 | 5 | 3 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 199 | 135 | 225 | 236 |
Total Liabilities & Shareholder's Equity | NA | 569 | 574 | 635 | 633 |
Total Common Equity | 0 | 199 | 135 | 225 | 236 |
Shares Outstanding | 48.70 | 48.10 | 39.20 | 37.70 | 33.90 |
Book Value Per Share | 0.00 | 4.14 | 3.44 | 5.98 | 6.96 |